NATTO : LETTER FROM KAPPA BIOSCIENCE
Oslo, Norway (11 June 2020) — Reference is made to the recent stock exchange notices regarding offers by Kappa Bioscience AS ("Kappa") to acquire shares in NattoPharma ASA ("NattoPharma" or the "Company") at an offer price per share of NOK 12.75 (the "Offer"), and NattoPharma Board of Directors' (the "Board") unanimous recommendation to the shareholders to not accept the Offer. NattoPharma has today received a letter from Kappa in which Kappa alleges that NattoPharma appears to be in infringement with Kappa's not granted European patent application no. 15193746.3 (EP3018116) and